GlassScriptPhysician profile
John G Carson
NPI 1871507228
$26,341.45
in general payments reported to CMS, 2019-2025
26 companies · $4,303 in 2025
The $4,303 reported for 2025 was more than what 83% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,875 · 2020: $124 · 2021: $2,794 · 2022: $402 · 2023: $14K · 2024: $2,580 · 2025: $4,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,100 · Food and Beverage: $6,295 · Travel and Lodging: $4,301 · Consulting Fee: $2,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,100.00 |
| Food and Beverage | $6,295.24 |
| Travel and Lodging | $4,301.15 |
| Consulting Fee | $2,450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,232.77 | 2019-2025 | Varithena Administration Pack, General - Vascular Intervention, Eluvia |
| Cordis US Corp. | $4,598.74 | 2021-2023 | Saber |
| W. L. Gore & Associates, INC. | $2,365.35 | 2022-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Medtronic, INC. | $2,110.20 | 2021-2025 | Endurant Iis, Venaseal, Valiant Captivia |
| Vb Spine LLC | $1,774.04 | 2025 | Stryker, Es2 Spinal System |
| Penumbra, INC. | $1,313.40 | 2019-2024 | Indigo System |
| Becton, Dickinson and Company | $552.33 | 2023-2024 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Cook Medical LLC | $518.57 | 2019-2025 | Lunderquist, Zenith Spiral-Z |
| Silk Road Medical, INC. | $431.98 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $401.30 | 2019-2022 | |
| Smith+Nephew, INC. | $347.30 | 2023-2025 | Stravix Pl, Stravix, Grafix Pl |
| Shockwave Medical, INC | $342.57 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $233.87 | 2019-2024 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Reflow Medical INC | $176.67 | 2025 | |
| Stryker Corporation | $156.41 | 2025 | Limflow System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $155.96 | 2025 | Esprit, Xact |
| Lemaitre Vascular, INC. | $150.24 | 2025 | Restoreflow, Pruitt F3 Carotid Shunt |
| Philips North America LLC | $133.67 | 2024 | (Br5) Peripheral Ivus |
| Cardinal Health 200 LLC | $116.88 | 2019 | |
| Bone Support INC. | $84.66 | 2025 | Cerament G, Ceramentbone Void Filler |
| Organogenesis INC. | $39.56 | 2021-2022 | |
| Getinge USA Sales, LLC | $27.60 | 2021 | |
| Convatec INC. | $26.67 | 2020 | |
| Cardiva Medical, INC. | $18.61 | 2022 | |
| Medtronic Vascular, INC. | $17.95 | 2019 | |
| Inari Medical, INC. | $14.15 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.